These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3673669)

  • 1. Hydroxyurea treatment of myeloproliferative disorders. Macro-megaloblastic blood and bone marrow changes.
    Löfvenberg E; Nilsson T; Wahlin A; Jacobsson L
    Acta Med Scand; 1987; 222(2):169-74. PubMed ID: 3673669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dyserythropoietic changes and sideroblastic anemia in patients with hairy cell leukemia before and after therapy with 2-chlorodeoxyadenosine.
    Zák P; Chrobák L; Podzimek K; Plísková L; Dedic K
    Neoplasma; 1998; 45(4):261-5. PubMed ID: 9890671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Megaloblastic anaemia: prevalence and causative factors.
    Khanduri U; Sharma A
    Natl Med J India; 2007; 20(4):172-5. PubMed ID: 18085121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow findings before and after treatment with recombinant human erythropoietin in chronic hemodialyzed patients.
    Ahn JH; Yoon KS; Lee WI; Suh JT; Lee TW; Ihm CG; Kim MJ
    Clin Nephrol; 1995 Mar; 43(3):189-95. PubMed ID: 7774077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-induced megaloblastic change.
    Scott JM; Weir DG
    Clin Haematol; 1980 Oct; 9(3):587-606. PubMed ID: 6450011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of serum soluble transferrin receptor levels and comparison with bone marrow iron stores as an index for iron-deficient erythropoiesis in a heterogeneous group of patients.
    Chang J; Bird R; Clague A; Carter A
    Pathology; 2007 Jun; 39(3):349-53. PubMed ID: 17558864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic radiation-induced alteration in hematopoietic repair during preclinical phases of aplastic anemia and myeloproliferative disease: assessing unscheduled DNA synthesis responses.
    Seed TM; Meyers SM
    Cancer Res; 1993 Oct; 53(19):4518-27. PubMed ID: 8402623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombopoietin administered during induction chemotherapy to patients with acute myeloid leukemia induces transient morphologic changes that may resemble chronic myeloproliferative disorders.
    Douglas VK; Tallman MS; Cripe LD; Peterson LC
    Am J Clin Pathol; 2002 Jun; 117(6):844-50. PubMed ID: 12047134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sideroblast content of the bone marrow at the end of pregnancy or 1st days of puerperium, respectively].
    Hadnagy C; Márkus T; Szurkos I
    Zentralbl Gynakol; 1977; 99(18):1106-7. PubMed ID: 919885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hematological abnormalities in alcoholism].
    Homann C; Hasselbalch HC
    Ugeskr Laeger; 1992 Aug; 154(32):2184-7. PubMed ID: 1509602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Toxic alcohol dysmyelopoiesis--bone marrow histology studies of a forensic medicine autopsy sample].
    Hellerich U; Budde R
    Beitr Gerichtl Med; 1992; 50():69-74. PubMed ID: 1489357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo effects of recombinant human erythropoietin on bone marrow hematopoiesis in patients with chronic renal failure.
    Biljanović-Paunović L; Djukanović L; Lezaić V; Stojanović N; Marisavljević D; Pavlović-Kentera V
    Eur J Med Res; 1998 Dec; 3(12):564-70. PubMed ID: 9889177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Megaloblastic erythropoiesis in stem cell leukemias].
    Kraus W
    Z Gesamte Inn Med; 1981 Feb; 36(3):82-5. PubMed ID: 7222855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute erythroid neoplastic proliferations. A biological study based on 62 patients.
    Domingo-Claros A; Larriba I; Rozman M; Irriguible D; Vallespí T; Aventin A; Ayats R; Millá F; Solé F; Florensa L; Gallart M; Tuset E; Lopez C; Woessner S
    Haematologica; 2002 Feb; 87(2):148-53. PubMed ID: 11836165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term intake of a high zinc diet causes iron deficiency anemia accompanied by reticulocytosis and extra-medullary erythropoiesis.
    Yanagisawa H; Miyakoshi Y; Kobayashi K; Sakae K; Kawasaki I; Suzuki Y; Tamura J
    Toxicol Lett; 2009 Dec; 191(1):15-9. PubMed ID: 19651194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WHO bone marrow features and European clinical, molecular, and pathological (ECMP) criteria for the diagnosis of myeloproliferative disorders.
    Michiels JJ; De Raeve H; Hebeda K; Lam KH; Berneman Z; Schroyens W; Schwarz J
    Leuk Res; 2007 Aug; 31(8):1031-8. PubMed ID: 17367853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I study using combination of hydroxyurea and 5-azacytidine (NSC-102816).
    Lomen PL; Khilanani P; Kessel D
    Neoplasma; 1980; 27(1):101-6. PubMed ID: 6154898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of hydroxyurea on hemopoiesis in the rat after single or fractional administration].
    Haas RJ; Fache I; Bohne F; Fliedner TM
    Arzneimittelforschung; 1971 Jul; 21(7):974-8. PubMed ID: 5109512
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hydroxyurea-induced leg ulcers in patients with chronic myeloproliferative disorders].
    Olesen LH; Pedersen BB
    Ugeskr Laeger; 2001 Dec; 163(49):6908-11. PubMed ID: 11766504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.